The susceptible HLA class II alleles and their presenting epitope(s) in goodpasture's disease

Y. Shi,L. Xie,Z. Cui,F. Chen,Z. -Y. Pei,X. -Y. Jia,M. -H. Zhao
DOI: https://doi.org/10.1111/imm.12736
2019-01-01
Immunology
Abstract:Goodpasture's disease is closely associated with HLA, particularly DRB1*1501. Other susceptible or protective HLA alleles are not clearly elucidated. The presentation models of epitopes by susceptible HLA alleles are also unclear. We genotyped 140 Chinese patients and 599 controls for four-digit HLA II genes, and extracted the encoding sequences from the IMGT/HLA database. T-cell epitopes of 3(IV)NC1 were predicted and the structures of DR molecule-peptideT-cell receptor were constructed. We confirmed DRB1*1501 (OR = 46, P = 57 x 10(-28)) to be a risk allele for Goodpasture's disease. Arginine at position 13 (ARG13) (OR = 40, P = 10 x 10(-17)) and proline at position 11 (PRO11) (OR = 40, P = 20 x 10(-17)) on DR1, encoded by DRB1*1501, were associated with disease susceptibility. (134-148) (HGWISLWKGFSFIMF) was predicted as a T-cell epitope presented by DRB1*1501. Isoleucine(137), tryptophan(140), glycine(142), phenylalanine(143) and phenylalanine(145), were presented in peptide-binding pockets 1, 4, 6, 7 and 9 of DR2b, respectively. ARG13 in pocket 4 interacts with tryptophan(140) and forms a hydrogen bond. In conclusion, we propose a mechanism for DRB1*1501 susceptibility for Goodpasture's disease through encoding ARG13 and PRO11 on MHC-DR1 chain and presenting T-cell epitope, (134-148), with five critical residues.
What problem does this paper attempt to address?